Swiss drugmakers Novartis and Roche ditch some diversity programmes on US concerns
Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...
Parties unite against US drugmakers, a referendum flops and Plibersek won’t help Labor much in Tasmania
A referendum dies before it is born, US drug makers find an enemy in both of Australia’s major parties and a popular Labor ...
Why US drug giants are so angry about Australia’s PBS
US pharmaceutical giants hope the protectionist Trump administration will force Australia to increase the price it pays for ...
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger
Mallinckrodt and Endo , drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced ...
Drugmakers Mallinckrodt and Endo to merge in nearly $7 billion deal
Mallinckrodt and Endo, drugmakers with a shared history of bankruptcy and U.S. opioid litigation, will merge in a deal valued ...
Devdiscourse1d
Drugmakers Battle Against Tariffs on Medicinal Goods
The pharmaceutical industry is urging the Trump administration and European Union to exclude medical goods from tariff ...
Fierce Pharma1d
IRA round 2 begins as drugmakers sign on to price negotiation process with CMS
Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...
For small drugmakers playing fast and loose with quality, trouble is on way
The stringent action is meant to prevent criticism of quality of drugs produced in the country and to prevent any non-tariff ...
Drugmakers Mallinckrodt and Endo Are in Talks to Merge
Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...
Fierce Healthcare1d
RFK Jr.'s HHS picks up Biden admin legal fight against 340B rebates
The Department of Health and Human Services (HHS) has filed for summary judgment in its favor regarding lawsuits brought by ...
STAT4d
U.K. plan to require drugmakers to pay higher rebates draws criticism from industry group
The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service.
Colorado bill would remake federal program that subsidizes hospitals in bid to lower patients’ costs
During the pandemic, hospitals expanded the amount of 340B revenue they took in by partnering with other pharmacies, and drug makers retaliated by limiting those partnerships.